• The New Money
  • Posts
  • Nuclear AI Power, Neuroscience On The Nasdaq, And Fentanyl Testing Strips Coming To The USA

Nuclear AI Power, Neuroscience On The Nasdaq, And Fentanyl Testing Strips Coming To The USA

Uncovering the world’s most exciting early stage companies. Discover what’s next.

Powering Artificial Intelligence With Nuclear Energy

NANO Nuclear Energy (NASDAQ: NNE) has entered into a new partnership with Blockfusion to power artificial intelligence cloud computing through their micro reactor technology. The collaboration will focus on potential ways to integrate nuclear power onsite at data centres to provide electricity for artificial intelligence cloud computing through leveraging NANO Nuclear’s micro reactors, which are purpose built for remote applications due to their small size.

A New Neuroscience Company Debuts On Nasdaq

Firefly Neuroscience (NASDAQ: AIFF) officially began trading on the Nasdaq this morning. The company’s AI platform Brain Network Analytics was previously cleared by the FDA and provides insight into brain imaging, enabling more precise diagnoses and potential treatment options for individuals dealing with dementia and mental health conditions.

Fentanyl Testing Strips Are Coming To The USA

Greenlane Holdings (NASDAQ: GNLN) has agreed to become the exclusive distributor of Safety Strips’ fentanyl testing products across the United States. The strips can quickly determine the presence of fentanyl in drugs, and can play an important role in avoiding overdoses, which have become an enormous public health crisis.

The Sprint

New here? Join our community of 25,000+ individuals interested in uncovering the world’s most exciting early stage companies.

Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.